NPTH Relative Valuation - NeuPath Health Inc

Watchlist Manager

Watchlist

Price: 0.46 CAD

Market Cap: CA$25.8m

	NeuPath Health Inc XTSX:NPTH	CA
	Community Capital Bancshares Inc OTC:ALBY	US
S	Suntrust Resort Holdings Inc XPHS:SUN	PH
	Pioneering Technology Corp XTSX:PTE	CA
	Foschini Group Ltd OTC:FHHGF	ZA
C	Caterpillar Inc SGO:CAT	US

Relative Value

NPTH doesn't have a meaningful market cap.

The Relative Value of one NPTH stock under the Base Case scenario is hidden CAD. Compared to the current market price of 0.46 CAD, NeuPath Health Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Relative Value calculated?

NPTH Relative Value

Show

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
CA		NeuPath Health Inc XTSX:NPTH	25.9m CAD	0.3	-46.8	7.1	14.2
US		CVS Health Corp NYSE:CVS	90.9B USD	0.2	51.1	13.4	13.4
US	C	Cigna Group XMUN:CGN	67.4B EUR	0.3	13	7.6	9.7
US		Cigna Corp NYSE:CI	69.2B USD	0.2	11.5	0	0
DE		Fresenius SE & Co KGaA XETRA:FRE	24.6B EUR	1.1	19.7	9.3	13.9
DE		Fresenius Medical Care AG XMUN:FME	22.5B EUR	1.1	23	8.9	16.4
US		Laboratory Corporation of America Holdings NYSE:LH	21.6B USD	1.6	25	12	17.4
US		Quest Diagnostics Inc NYSE:DGX	21.5B USD	2	21.9	11.9	16
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	10.5B EUR	0.5	10.8	5.2	9.7
US		Guardant Health Inc NASDAQ:GH	11.1B USD	11.3	-26.7	-29.3	-26.6
US		DaVita Inc NYSE:DVA	10.2B USD	0.8	13.9	7.2	9.8

				Revenue Growth	P/S to Growth
CA		NeuPath Health Inc XTSX:NPTH	Average P/S: 1.8 0.3	N/A	N/A
US		CVS Health Corp NYSE:CVS	0.2	4%	0.1
US	C	Cigna Group XMUN:CGN	0.3	6%	0
US		Cigna Corp NYSE:CI	0.2	6%	0
DE		Fresenius SE & Co KGaA XETRA:FRE	1.1	5%	0.2
DE		Fresenius Medical Care AG XMUN:FME	1.1	3%	0.4
US		Laboratory Corporation of America Holdings NYSE:LH	1.6	6%	0.3
US		Quest Diagnostics Inc NYSE:DGX	2	5%	0.4
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	0.5	3%	0.2
US		Guardant Health Inc NASDAQ:GH	11.3	29%	0.4
US		DaVita Inc NYSE:DVA	0.8	4%	0.2

				Earnings Growth	PEG
CA		NeuPath Health Inc XTSX:NPTH	Average P/E: 21.1 Negative Multiple: -46.8	N/A	N/A
US		CVS Health Corp NYSE:CVS	51.1	90%	0.6
US	C	Cigna Group XMUN:CGN	13	19%	0.7
US		Cigna Corp NYSE:CI	11.5	19%	0.6
DE		Fresenius SE & Co KGaA XETRA:FRE	19.7	26%	0.8
DE		Fresenius Medical Care AG XMUN:FME	23	16%	1.4
US		Laboratory Corporation of America Holdings NYSE:LH	25	27%	0.9
US		Quest Diagnostics Inc NYSE:DGX	21.9	12%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	10.8	16%	0.7
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -26.7	N/A	N/A
US		DaVita Inc NYSE:DVA	13.9	20%	0.7

				EBITDA Growth	EV/EBITDA to Growth
CA		NeuPath Health Inc XTSX:NPTH	Average EV/EBITDA: 9.2 7.1	N/A	N/A
US		CVS Health Corp NYSE:CVS	13.4	28%	0.5
US	C	Cigna Group XMUN:CGN	7.6	4%	1.9
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	9.3	10%	0.9
DE		Fresenius Medical Care AG XMUN:FME	8.9	7%	1.3
US		Laboratory Corporation of America Holdings NYSE:LH	12	10%	1.2
US		Quest Diagnostics Inc NYSE:DGX	11.9	6%	2
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	5.2	7%	0.7
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -29.3	N/A	N/A
US		DaVita Inc NYSE:DVA	7.2	4%	1.8

				EBIT Growth	EV/EBIT to Growth
CA		NeuPath Health Inc XTSX:NPTH	Average EV/EBIT: 13.4 14.2	N/A	N/A
US		CVS Health Corp NYSE:CVS	13.4	22%	0.6
US	C	Cigna Group XMUN:CGN	9.7	5%	1.9
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	13.9	12%	1.2
DE		Fresenius Medical Care AG XMUN:FME	16.4	11%	1.5
US		Laboratory Corporation of America Holdings NYSE:LH	17.4	18%	1
US		Quest Diagnostics Inc NYSE:DGX	16	9%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	9.7	11%	0.9
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -26.6	N/A	N/A
US		DaVita Inc NYSE:DVA	9.8	5%	2

NeuPath Health Inc
XTSX:NPTH

Relative Value

Valuation Multiples

Multiples Across Competitors

NPTH Competitors Multiples
NeuPath Health Inc Competitors

See Also

Company

Help

Tools

Stocks

NeuPath Health Inc XTSX:NPTH

Relative Value

Valuation Multiples

Multiples Across Competitors

NPTH Competitors Multiples NeuPath Health Inc Competitors

See Also

Company

Help

Tools

Stocks

NeuPath Health Inc
XTSX:NPTH

NPTH Competitors Multiples
NeuPath Health Inc Competitors